Because they have insulin resistance, lower early-phase insulin secretion prevents those with type 2 diabetes from being able to perform the metabolic mechanisms necessary for glucose uptake, further contributing to hyperglycemia and T2D. The gene discussed is INS; the disease is Insulin resistance.